Binding members for IgE molecules

Details for Australian Patent Application No. 2012238233 (hide)

Owner AstraZeneca AB MedImmune Limited

Inventors Cochrane, Duncan; Cohen, Suzanne; Dobson, Claire Louise; Eriksson, PerOlof Fredrik; Monk, Phillip David; VonWachenfeldt, Karin

Agent Davies Collison Cave

Pub. Number AU-A-2012238233

Parent 2008216008

Filing date 5 October 2012

Wipo publication date 1 November 2012

International Classifications

C07K 16/42 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/00 Drugs for disorders of the respiratory system

A61P 37/08 Drugs for immunological or allergic disorders

C07K 14/705 Peptides having more than 20 amino acids

C07K 16/26 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 19/00 Hybrid peptides

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

25 October 2012 Complete Application Filed

1 November 2012 Application Open to Public Inspection

  Published as AU-A-2012238233

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012238234-Payment System and Method

2012238232-Cloth treating apparatus